Hepatology and Autoimmune Cholestatic Disease
Clinical research includes primary biliary cholangitis and primary sclerosing cholangitis, with attention to liver-related symptoms, biochemical markers, and longer-term disease control in adults.
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- Cholestatic liver disease
- Liver function biomarkers
The sponsor’s portfolio in this area reflects a focus on conditions that affect bile flow, hepatic inflammation, and progression to advanced liver disease.
Metabolic Liver Injury and Fibrotic Liver Disease
Its studies also address cirrhosis and related complications within primary biliary cholangitis, highlighting interest in progressive liver damage and clinical outcomes linked to chronic hepatic disease.
- Cirrhosis
- Fibrotic liver disease
- Clinical outcome events
- Alkaline phosphatase normalization
Research activity in this domain centers on disease burden, liver-related progression, and measurable indicators of cholestatic activity.
Gastrointestinal Oncology
Another area of interest is metastatic pancreatic adenocarcinoma, with trials focused on systemic treatment options for advanced pancreatic cancer in adults who have not previously received chemotherapy.
- Metastatic pancreatic adenocarcinoma
- Pancreatic cancer
- Overall survival
- Combination chemotherapy
This oncology work places emphasis on difficult-to-treat gastrointestinal malignancies and treatment strategies used in advanced-stage disease.
Adult Specialty Medicine
The sponsor’s active studies are concentrated in adult populations across hepatology and oncology, with a strong emphasis on chronic disease management and serious malignancies.
- Adult participants
- Chronic liver disorders
- Advanced cancer care
- Therapeutic tolerability
These clinical areas show a clear focus on diseases with substantial unmet medical need in specialist care settings.
